Lærke Smidt Gasbjerg

Lærke Smidt Gasbjerg


Research field: translational area between molecular pharmacology and clinical physiology focusing on the endocrine system and metabolism.

Expertise: peptide gut hormones related to nutrient metabolism involving ligand-receptor interactions, physiological actions, pathophysiological implications, and therapeutic potential. 

Key words: Peptide hormones, incretin effect, hormone physiology, pharmacology, GIP, GLP-1, GLP-2

Possible conflicts of interest

Co-founder of Antag Therapeutics, CVR 38402056

Selected publications

  1. Published

    GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation

    Mayendraraj, A., Rosenkilde, Mette & Gasbjerg, Lærke Smidt, 2022, In: Peptides. 151, p. 1-10 170749.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Effects of endogenous GIP in patients with type 2 diabetes

    Stensen, S., Gasbjerg, Lærke Smidt, Krogh, L. L., Skov-Jeppesen, Kirsa, Sparre-Ulrich, A. H., Jensen, M. H., Dela, Flemming, Hartmann, Bolette, Vilsbøll, Tina, Holst, Jens Juul, Rosenkilde, Mette, Christensen, Mikkel Bring & Knop, Filip Krag, Apr 2021, In: European Journal of Endocrinology. 185, 1, p. 33-45

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published
  4. Published

    Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists

    Gasbjerg, Lærke Smidt, Bergmann, N. C., Stensen, S., Christensen, Mikkel Bring, Rosenkilde, Mette, Holst, Jens Juul, Nauck, M. & Knop, Filip Krag, 2020, In: Peptides. 125, 10 p., 170183.

    Research output: Contribution to journalReviewResearchpeer-review

ID: 37775779